rbc life sciences inc (RBCL:OTC US)

Financial Statements for rbc life sciences inc (RBCL)

Currency in Millions of US Dollars	As of:	Dec 31 2009	Dec 31 2010	Dec 31 2011	Dec 31 2012	4 Year Trend
Revenues		24.9	28.2	28.4	25.2
TOTAL REVENUES		24.9	28.2	28.4	25.2
Cost of Goods Sold		12.1	14.5	14.1	12.5
GROSS PROFIT		12.8	13.7	14.3	12.6
Selling General & Admin Expenses, Total		12.6	12.2	13.9	13.0
Depreciation & Amortization, Total		0.4	0.5	0.4	0.5
OTHER OPERATING EXPENSES, TOTAL		13.0	12.6	14.4	13.5
OPERATING INCOME		-0.2	1.0	-0.1	-0.9
Interest Expense		-0.2	-0.2	-0.1	-0.1
NET INTEREST EXPENSE		-0.2	-0.2	-0.1	-0.1
EBT, EXCLUDING UNUSUAL ITEMS		-0.3	0.9	-0.2	-1.0
Other Unusual Items, Total		--	--	--	0.4
Insurance Settlements		--	--	--	0.4
EBT, INCLUDING UNUSUAL ITEMS		-0.3	0.9	-0.2	-0.6
Income Tax Expense		0.0	0.3	-0.1	-0.2
Earnings from Continuing Operations		-0.3	0.6	-0.1	-0.4
NET INCOME		-0.3	0.6	-0.1	-0.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		-0.3	0.6	-0.1	-0.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		-0.3	0.6	-0.1	-0.4

Report Data Issue

To contact RBC LIFE SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.